Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. ERBITUX (cetuximab)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ERBITUX (cetuximab)

Medicine - Posted on Jan 08 2016 - Updated on Jun 12 2019
Active substance (DCI)
  • cetuximab
history (5)
  • 12/2/15

    ERBITUX (cetuximab)

    Restriction de l'indication aux seuls patients ayant un cancer colorectal métastatique avec des gènes RAS (KRAS et N-RAS) no...
    CAV :
    54321
    icône flèche
  • 5/13/09

    ERBITUX

    Erbitux is indicated for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, KRAS wild-type m...
    CAV :
    54321
    icône flèche
  • 2/10/10

    ERBITUX

    -
    CAV :
    54321
    icône flèche
  • 10/18/06

    ERBITUX

    ERBITUX
    CAV :
    54321
    icône flèche
  • 3/16/05

    ERBITUX 2 mg/ml, solution pour perfusion (1 flacon (50 ml))

    ERBITUX 2 mg/ml, solution pour perfusion (1 flacon (50 ml))
    icône flèche
Technical information
ATC code
  • L01XC06
Manufacturer
MERCK SERONO
Presentation

ERBITUX 2 mg/ml, solution pour perfusion 1 flacon de 50 ml (CIP : 565 806–9)

ERBITUX 5 mg/ml, solution pour perfusion (code CIS : 66843357) : 1 flacon(s) en verre de 100 ml - Code CIP : 3400957075200 / 1 flacon(s) en verre de 20 ml - Code CIP : 3400957075088

All our publications
    Digestive system cancers Drug therapy Radiotherapy and physical agents Respiratory tract cancers Skin and connective tissue cancers

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
kECNWaSvptP3vRH0